Published in Biochem Soc Trans on January 01, 1978
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 11.61
The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem (1971) 3.73
A rapid haemagglutination test for hepatitis-B antigen. Lancet (1974) 3.31
A novel lymphotropic herpesvirus. Lancet (1987) 2.89
Hepatitis-B antigen in saliva and semen. Lancet (1974) 2.85
Hepatitis C virus: evidence for sexual transmission. BMJ (1991) 2.50
Liposomes as immunological adjuvants. Nature (1974) 2.37
Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol (1981) 2.16
The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med (1976) 2.03
Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. Biochem J (1972) 1.97
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J (1980) 1.97
Herpesvirus hominis infection of the cervix associated with gonorrhoea. Lancet (1968) 1.96
Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. Eur J Biochem (1972) 1.74
Drug entrapment in liposomes. FEBS Lett (1973) 1.73
Enzyme-containing liposomes alleviate a model for storage disease. Nature (1973) 1.63
Targeting of drugs. Nature (1977) 1.49
The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med (1976) 1.49
A comparison of different methods of screening blood donations for HBsAg. Vox Sang (1977) 1.48
Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem (1970) 1.47
Homing of liposomes to target cells. Biochem Biophys Res Commun (1975) 1.46
Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci (1982) 1.40
Pulmonary infiltration after exposure to home renovation dust: histopathology and microanalysis. Thorax (1996) 1.40
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta (1991) 1.37
A sensitive immunoradiometric assay for the detection of hepatitis B surface antigen. J Virol Methods (1980) 1.30
Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. Eur J Biochem (1974) 1.28
Structure of the hepatitis B virus genome. J Virol (1983) 1.27
A multiple sampling device for the mass screening of serum samples for hepatitis B surface antigen. J Clin Pathol (1978) 1.24
Drug-carrier potential of liposomes in cancer chemotherapy. Lancet (1974) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Experiences with solid-phase "radioimmunoassay" in the rapid diagnosis of hepatitis B. J Med Virol (1978) 1.21
Homing of liposomes to target cells. Biochem Soc Trans (1975) 1.20
An inexpensive, portable, battery-operated photometer for the reading of ELISA tests in microtitration plates. J Immunol Methods (1981) 1.19
Penetration of target areas in the rat by liposome-associated bleomycin, glucose oxidase and insulin. FEBS Lett (1976) 1.15
Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Biophys Res Commun (1979) 1.14
Targeting of drugs: implications in medicine. Lancet (1981) 1.13
Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology (1997) 1.11
Liposome-entrapped plasmid DNA: characterisation studies. Biochim Biophys Acta (2000) 1.09
The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett (1980) 1.08
Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol (1974) 1.08
Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology (1973) 1.08
Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat (2006) 1.07
Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine (2001) 1.07
Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine (1987) 1.06
Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Lett (1979) 1.06
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut (2007) 1.05
Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. J Immunol (1989) 1.05
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues. Life Sci (1977) 1.05
A sensitive single reverse passive haemagglutination test for detecting both HBsAg and anti-HBs. J Clin Pathol (1979) 1.04
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis (2010) 1.03
Hepatitis Bs antigen and liver cancer: A population based study in Kenya. Br J Cancer (1975) 1.03
Enzyme entrapment in liposomes. Methods Enzymol (1976) 1.03
Decreased monoamine oxidase activity in liver of iron-deficient rats. Can J Biochem (1969) 1.03
Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response. Immunol Lett (1987) 1.03
Late postoperative results in males treated for testicular torsion during childhood. J Pediatr Surg (1994) 1.03
Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics. Immunology (1987) 1.02
Liposomes as vehicles for the local release of drugs. Clin Sci Mol Med (1975) 1.01
Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum. FEBS Lett (1980) 1.00
Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett (1982) 1.00
Interaction of liposomes with blood plasma proteins. Biochem Soc Trans (1976) 0.98
Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut (1996) 0.98
Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats. Biochem J (1974) 0.98
The preparation of human articular cartilage for scanning electron microscopy. J Microsc (1976) 0.98
Viral hepatitis markers in blood donors with history of jaundice. Lancet (1980) 0.97
Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology (1988) 0.96
Novel sorbitan monostearate organogels. J Pharm Sci (1999) 0.96
Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol (1975) 0.95
Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase. Lancet (1977) 0.95
Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta (1985) 0.95
Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat (2010) 0.94
Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept. Ann N Y Acad Sci (1978) 0.94
Preparation of liposomes containing factor VIII for oral treatment of haemophilia. J Microencapsul (1989) 0.93
Polysialylated asparaginase: preparation, activity and pharmacokinetics. Biochim Biophys Acta (1997) 0.92
Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim Biophys Acta (1996) 0.90
Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers. Biochem J (1981) 0.90
The ultrastructural features of malakoplakia. J Pathol (1981) 0.90
Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target (1994) 0.89
Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. Lancet (1976) 0.89
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat (2008) 0.89
Tissue and hepatic subcellular distribution of liposomes containing bleomycin after intravenous administration to patients with neoplasms. Clin Sci Mol Med (1976) 0.89
The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vitro. Life Sci (1980) 0.88
Pegylated interferon-2b-associated autoimmune thrombocytopenia in a patient with chronic hepatitis C. Am J Gastroenterol (2003) 0.88
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2007) 0.87
Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice. FEBS Lett (1974) 0.87
Spontaneous loss of HBeAg and the prevalence of HTLV-III/LAV infection in a cohort of homosexual hepatitis B virus carriers and the implications for antiviral therapy. J Hepatol (1986) 0.86
Tritiation of glycoproteins. Biochem Biophys Res Commun (1973) 0.86
Radioimmunoassay and saturation analysis. Viruses. Br Med Bull (1974) 0.86
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents: attempts to improve localization in tumour tissues [proceedings]. Biochem Soc Trans (1977) 0.85
Water-in-sorbitan monostearate organogels (water-in-oil gels). J Pharm Sci (1999) 0.85
Interaction of a nonionic surfactant-based organogel with aqueous media. Int J Pharm (1999) 0.85
Liposomes in the therapy of lysosomal storage diseases. Nature (1978) 0.85
Intracellular distribution of copper in the liver of the rat. Can J Biochem (1967) 0.85
Primary malignant melanoma of the oesophagus. J Clin Pathol (1990) 0.85
Targeting of liposomes to accessible cells in vivo. Ann N Y Acad Sci (1985) 0.84
The use of monoclonal anti-Thy1 IgG1 for the targeting of liposomes to AKR-A cells in vitro and in vivo. Biochim Biophys Acta (1984) 0.84
Tumour regression with liposome-entrapped asparaginase: some immunological advantages. Biochem Soc Trans (1976) 0.84
Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection. Hepatology (1998) 0.84
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J (1971) 0.84
Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Dig Liver Dis (2007) 0.84